ENvue Medical Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Number of Hospital Deployments Quarterly38Target: Accelerated expansion across U.S. hospitals
U.S. Enteral Portfolio Revenue Growth QuarterlyTarget: Accelerate revenue across the enteral platform
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: Closing bid price below $1.00 for 30 consecutive business daysAction: Request a Nasdaq hearings panel review to stay delisting and seek stockholder approval for a reverse stock split at the special meeting on August 14, 2026.
- Going Concern Risk and Cash DepletionTrigger: Rapidly depleting cash reserves and high net lossesAction: Monitor cash runway, execute on commercialization strategy led by VP Commercial Marc Waldman, and evaluate potential financing or strategic alternatives.
- Commercial Adoption of ENvue Navigation PlatformTrigger: Expansion of platform deployments at existing major academic medical centersAction: Leverage clinical validation and repeat installations to deepen presence in high-volume healthcare markets like Dallas-Fort Worth.
Research as of 24 Jul 2026